Insiders · FDMT

FDMT insider transactions

4D Molecular Therapeutics Inc. (FDMT) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for FDMT

• 6d
  Officer Kirn David sold $737,410 worth of shares (58,333 units at $12.64) as part of a pre-agreed trading plan, decreasing direct ownership by 6% to 884,152 units (SEC Form 4)

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 18d
  Chief Legal Officer Bizily Scott sold $91,924 worth of shares (6,566 units at $14.00) as part of a pre-agreed trading plan and exercised 6,566 shares at a strike of $6.20 (SEC Form 4)

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 25d
  Chief Legal Officer Bizily Scott exercised 9,810 shares at a strike of $4.14 and sold $117,720 worth of shares (9,810 units at $12.00) (SEC Form 4)

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 27d
  Officer Kirn David sold $1,200,851 worth of shares (114,746 units at $10.47) as part of a pre-agreed trading plan, decreasing direct ownership by 11% to 942,485 units (SEC Form 4)

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 32d
  SEC Form 4 filed by Director Tomasello Shawn

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 32d
  SEC Form 4 filed by Director Theuer Charles

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 32d
  SEC Form 4 filed by Director Miller-Rich Nancy

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 32d
  SEC Form 4 filed by Director Gray Susannah

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 32d
  SEC Form 4 filed by Director Milligan John F

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 32d
  SEC Form 4 filed by Director Sblendorio Glenn

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 32d
  SEC Form 4 filed by Director Chacko Jacob

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 48d
  Officer Kirn David sold $19,258 worth of shares (1,922 units at $10.02) as part of a pre-agreed trading plan, decreasing direct ownership by 0.18% to 1,057,231 units (SEC Form 4)

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 115d
  SEC Form 4 filed by Simms Christopher Paul

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 115d
  SEC Form 4 filed by Kirn David

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 115d
  SEC Form 4 filed by Bizily Scott

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 118d
  SEC Form 4 filed by Gupta Ashoo

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 193d
  SEC Form 4 filed by Director Sblendorio Glenn

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 193d
  SEC Form 3 filed by new insider Sblendorio Glenn

  3 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 208d
  VP, Finance and Controller Gupta Ashoo converted options into 1,086 shares and sold $3,377 worth of shares (389 units at $8.68), increasing direct ownership by 2% to 46,359 units (SEC Form 4)

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 213d
  SEC Form 3 filed by new insider Simms Christopher Paul

  3 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 213d
  Chief Legal Officer Bizily Scott exercised 1,635 shares at a strike of $4.14 and sold $17,822 worth of shares (1,635 units at $10.90) (SEC Form 4)

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 216d
  Director Theuer Charles exercised 9,333 shares at a strike of $1.14, increasing direct ownership by 29% to 41,684 units (SEC Form 4)

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 221d
  SEC Form 4 filed by Chief Financial Officer Humer Kristian

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 221d
  SEC Form 3 filed by new insider Humer Kristian

  3 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 242d
  Chief Legal Officer Bizily Scott sold $17,315 worth of shares (1,635 units at $10.59) and exercised 1,635 shares at a strike of $4.14 (SEC Form 4)

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 266d
  Chief Legal Officer Bizily Scott exercised 1,084 shares at a strike of $6.49 and sold $32,136 worth of shares (2,678 units at $12.00), decreasing direct ownership by 31% to 3,594 units (SEC Form 4)

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 273d
  Chief Legal Officer Bizily Scott sold $16,628 worth of shares (1,635 units at $10.17) and exercised 1,635 shares at a strike of $4.14 (SEC Form 4)

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 279d
  Chief Legal Officer Bizily Scott sold $24,080 worth of shares (2,408 units at $10.00), decreasing direct ownership by 32% to 5,188 units (SEC Form 4)

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 283d
  New insider Gupta Ashoo claimed ownership of 45,662 shares (SEC Form 3)

  3 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 296d
  Chief Legal Officer Bizily Scott sold $19,256 worth of shares (2,407 units at $8.00), decreasing direct ownership by 24% to 7,596 units (SEC Form 4)

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 395d
  SEC Form 4 filed by Director Chacko Jacob

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 395d
  SEC Form 4 filed by Director Gray Susannah

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 395d
  SEC Form 4 filed by Director Tomasello Shawn

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 395d
  SEC Form 4 filed by Director Theuer Charles

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 395d
  SEC Form 4 filed by Director Miller-Rich Nancy

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 395d
  SEC Form 4 filed by Director Milligan John F

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 497d
  SEC Form 4 filed by Chief Legal Officer Bizily Scott

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 497d
  SEC Form 4 filed by Chief Executive Officer Kirn David

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 497d
  SEC Form 4 filed by Chief Medical Officer Kim Robert Young

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 497d
  SEC Form 4 filed by Officer Mehra Uneek

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 497d
  SEC Form 4 filed by President & COO Kamal Fariborz

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 587d
  Large owner Ra Capital Management, L.P. disposed of 535,000 shares (SEC Form 4)

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 602d
  New insider Ra Capital Management, L.P. claimed ownership of 5,098,211 shares (SEC Form 3)

  3 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 614d
  See Explanation of Responses Bvf Partners L P/Il disposed of 5,680,000 shares (SEC Form 4)

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 670d
  Chief Legal Officer Bizily Scott exercised 500 shares at a strike of $6.49 and sold $8,165 worth of shares (500 units at $16.33) (SEC Form 4)

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 698d
  Chief Legal Officer Bizily Scott exercised 500 shares at a strike of $6.49 and sold $7,500 worth of shares (500 units at $15.00) (SEC Form 4)

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 718d
  New insider Bvf Partners L P/Il claimed ownership of 7,261,118 shares (SEC Form 3)

  3 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 732d
  Chief Legal Officer Bizily Scott exercised 1,750 shares at a strike of $7.60 and sold $47,442 worth of shares (1,750 units at $27.11) (SEC Form 4)

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 735d
  Chief Legal Officer Bizily Scott exercised 1,996 shares at a strike of $15.78 and sold $49,900 worth of shares (1,996 units at $25.00) (SEC Form 4)

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 738d
  Chief Executive Officer Kirn David exercised 12,923 shares at a strike of $14.55 and sold $290,598 worth of shares (12,923 units at $22.49) (SEC Form 4)

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 747d
  Chief Legal Officer Bizily Scott exercised 4,248 shares at a strike of $7.55 and sold $90,758 worth of shares (4,248 units at $21.36) (SEC Form 4)

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 754d
  Chief Executive Officer Kirn David exercised 12,930 shares at a strike of $14.42 and sold $298,711 worth of shares (12,930 units at $23.10) (SEC Form 4)

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 760d
  Chief Legal Officer Bizily Scott sold $41,494 worth of shares (1,750 units at $23.71) and exercised 1,750 shares at a strike of $7.60 (SEC Form 4)

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 788d
  SEC Form 4 filed by Tomasello Shawn

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 788d
  SEC Form 4 filed by Chacko Jacob

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 788d
  SEC Form 4 filed by Theuer Charles

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 788d
  SEC Form 4 filed by Miller-Rich Nancy

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 788d
  SEC Form 4 filed by Milligan John F

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 788d
  SEC Form 4 filed by Gray Susannah

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)
• 791d
  Bizily Scott exercised 1,750 shares at a strike of $7.60 and sold $44,541 worth of shares (1,750 units at $25.45) (SEC Form 4)

  4 - 4D Molecular Therapeutics, Inc. (0001650648) (Issuer)